Haemoglobinopathy in Slovakia - Abstract
Objectives: The paper presents results of 27- year epidemiological study of screening and follow-up haemoglobinopathies in Slovakia.Methods: Between 1993 – 2020, in two research centres in Bratislava and in one centre in Kosice, carriers of beta-thalassaemic genes or other haemoglobinopathies were searched for. Diagnosis was performed by haematologists, whereby the family history was evaluated, together with overall clinical condition, blood count and blood smear, iron and haemolysis parameters, mutations of hereditary haemochromatosis, and haemoglobin electrophoresis testing. Patients with a probability of having a haemoglobinopathy were sent to the research facilities.
Results: 415 patients were genetically examined. In 385 (92.77%), of them heterozygote beta-thalassaemia was confirmed (in 98 families). Five patients were diagnosed for delta, beta-thalassaemia (1.20%), 4 patients (0.97%) for delta, beta-gama1-thalasaemia or persistent hereditary fetal haemoglobin. In total we diagnosed 20 mutations of betaglobin gene. The most frequent mutations were IVS 1.110 (G-A), IVS II-1(G-A) and codon 39. Evidence of haemoglobin S (heterozygote sickle cell anaemia), was also notable in two non-relative children, whose fathers were of African origin, in one patient of Ghana and in one patient from Nigeria. One female patient was followed up for haemoglobin Santa Ana (mutation de novo), one family for haemoglobin Bishopstown and one patient for mutation KLF1 gene.
In our group were 14 patients (3.17%) diagnosed for alpha-thalassaemia.
All patients were heterozygotes, only one female patient from Macedonia was a double heterozygote for beta-thalasaemie.
Clinicaly all of the patients had a minor or intermedia form.
In the years of 2012-2019 we observed 12 pregnant patients with beta-thalasaemie. One of them had multiple pregnancies, all deliveries were without haematological complications.
Conclusions: The study showed that in the west and eastern Slovakia there is a higher number for thalassaemia and other haemoglobinopathies. Mutations are of historical origin or over the past years we have recorded an increase number of mutations from areas with high incidence of haemoglobinopathies. It is necessary to continue in search of pathological gene carriers to avoid serious forms of the disease.